Latest medication, pharmacy and healthcare news from MediSearcher, covering drug access, pricing, reimbursement, online pharmacy, telehealth, shortages and regulatory developments in the US, UK, Europe and Australia.
MEDISEARCHER NEWS European Union · Polymyalgia Rheumatica · 23 October 2026 In brief The European Commission has approved Cosentyx (secukinumab) for certain adults with polymyalgia rheumatica, or PMR. The new indication covers adults who have had an inadequate response to glucocorticoids or experience a relapse while glucocorticoids are being tapered. Cosentyx is the first IL-17A … Read more
MEDISEARCHER NEWS European Union · Achondroplasia treatment · 20 October 2026 In brief The European Medicines Agency’s human medicines committee has recommended EU marketing authorisation for Yuviwel (navepegritide) for children with achondroplasia. Yuviwel is administered by subcutaneous injection once a week, offering a substantially less frequent dosing schedule than the existing daily CNP-based treatment Voxzogo. … Read more
MEDISEARCHER NEWS European Union · Naloxone and opioid overdose · 19 October 2026 In brief The European Medicines Agency’s human medicines committee has recommended changing the legal status of Nyxoid (naloxone) so that it can be made available without a medical prescription. Nyxoid is a single-dose naloxone nasal spray used as emergency treatment for known … Read more
MEDISEARCHER NEWS United States · Thyroid eye disease · 18 October 2026 In brief The FDA has approved Enspryng (satralizumab-mwge) for adults with thyroid eye disease (TED). It is the first FDA-approved subcutaneous treatment for TED that can be administered at home by a patient or caregiver after appropriate training. During maintenance treatment, Enspryng is … Read more
MEDISEARCHER NEWS European Union · Weight management and type 2 diabetes · 17 October 2026 In brief The European Medicines Agency’s human medicines committee has recommended EU marketing authorisation for Foundayo (orforglipron), a once-daily oral GLP-1 medicine for weight management and type 2 diabetes. Foundayo is a tablet rather than an injection and can be … Read more
MEDISEARCHER NEWS United Kingdom · Weight-loss medicines · 16 October 2026 In brief UK authorities have seized more than 12,000 fake retatrutide and tirzepatide injection pens during a raid on an industrial unit in Birmingham. The Medicines and Healthcare products Regulatory Agency (MHRA) estimates the seized products were worth approximately £2 million. Investigators also found … Read more
MEDISEARCHER NEWS European Union · Pancreatic cancer · 16 October 2026 In brief The European Medicines Agency’s medicines committee has recommended Rasonque (daraxonrasib) for adults with metastatic pancreatic adenocarcinoma who have received at least one previous systemic treatment. In the pivotal Phase 3 trial, median overall survival was 12.4 months with daraxonrasib compared with 6.7 … Read more
MEDISEARCHER NEWS US / Canada · Prescription Access · Last updated 6 November 2026 In brief: U.S. Customs and Border Protection (CBP) has extended a key compliance deadline affecting certain international mail shipments from October 22, 2026 to January 20, 2027. The 90-day extension postpones those Entry Type 13 requirements until January 20. A separate … Read more
MEDISEARCHER NEWS Global · Pulmonary fibrosis · 14 October 2026 In brief Admilparant, an experimental oral treatment for idiopathic pulmonary fibrosis (IPF), has met the primary endpoint in a pivotal Phase 3 clinical trial. The 60 mg twice-daily dose produced a statistically significant benefit in lung function at 52 weeks compared with placebo. The higher … Read more
MEDISEARCHER NEWS Ireland · GLP-1 access · Updated 15 October 2026 In brief Ireland’s HSE Drugs Group considered Mounjaro (tirzepatide) at its meeting on 13 October but did not make a reimbursement recommendation. Mounjaro remains available by prescription in Ireland but is not currently covered by the Medical Card, Long-Term Illness Scheme or Drugs Payment … Read more
